Category Archives: Castration Resistant Prostate Cancer

PSMA-directed EndoRadiotherapy of Castration-resISTant prostate cancer (PERCIST). A phase II clinical trial.

Theranostics for Castration Resistance Metastatic Prostate Cancer

Posted in Castration Resistant Prostate Cancer, Theranostics, Treatments for Prostate Cancer | Tagged | Leave a comment

Cryoablation Immuno Therapy

Clinical Study Phase I Cryoimmunotherapy against Metastatic prostate Cancer Disease. Dr. Israel Barken, the Medical Director of the Prostate Cancer Research and Education, presents a clinical study phase I, featuring cryosurgery plus immuno-Modulator – Cyclophosphamide and Anti CTLA 4 Antibodies- … Continue reading

Posted in Castration Resistant Prostate Cancer, Clinical Trials, Immune Therapy, Prostate Cancer, Treatments for Prostate Cancer, Vaccine | Leave a comment

Phase III Prostvac Clinical Study

Immune Therapy is an important tool for advanced prostate cancer disease, especially in older patients for whom chemotherapy is excluded because of other serious medical problems. Dr. Barken presents the Prostvac Clinical Study Phase III with a video clip featuring … Continue reading

Posted in Active Surveillance, Ask Dr. Barken, Castration Resistant Prostate Cancer, Clinical Trials, Immune Therapy, Metastatic Disease, Prostate Cancer, PSA | Leave a comment

Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery.

Predictors for response to intermittent androgen    deprivation (IAD) in prostate cancer cases with biochemical progression after surgery. Authors Sciarra A, et al. -Urol Oncol. 2013 Jul;31(5):607-14. Abstract presented and comments included by Dr. Israel Barken, the medical director of the … Continue reading

Posted in Castration Resistant Prostate Cancer, Intermittent Hormonal Blockade, Prognosis, Radical Prostatectomy, Treatments for Prostate Cancer | Tagged | Leave a comment

Guidelines for Castration Resistant Prostate Cancer

This video includes list of new medications approved by FDA and other medications under study for Castration Resistant Prostate Cancer. The guidelines were published by the American Urological Association 2013

Posted in Castration Resistant Prostate Cancer | Leave a comment

Treatment options post Taxotere

Question of the week:  What’s available after Taxotere for a patient with bone metastatic disease? Dr. Barken talks to a caller about his options for treatment after chemotherapy. For the Ask Dr Barken Call In Show on Tuesday, Dec. 18th at 6pm … Continue reading

Posted in Castration Resistant Prostate Cancer, Coaching, Metastatic Disease, Treatments for Prostate Cancer | Leave a comment

MDV 3100 Clinical Study

Question of the week: What’s the latest on the MDV 3100 clinical study?  What is the mode of action of this oral drug?   Video Blog Presentation: Dr. Celestia Higano will talk about the status of the drug and info about … Continue reading

Posted in Castration Resistant Prostate Cancer, Hormonal Blockade, Hormone Refractory Disease, Metastatic Disease, Treatments for Prostate Cancer | Tagged | Leave a comment